Open access peer-reviewed chapter

Soybean in Monogastric Nutrition: Modifications to Add Value and Disease Prevention Properties

By Samuel N. Nahashon and Agnes K. Kilonzo-Nthenge

Submitted: March 19th 2012Reviewed: September 3rd 2012Published: February 20th 2013

DOI: 10.5772/52991

Downloaded: 2182

1. Introduction

Soybean (Glycine max), a leguminous oilseed and one of the world’s largest and most efficient sources of plant protein, has on average crude protein content of about 37-38% and 20% fat on a dry matter basis. The crude protein content of soybean varies with geographical region and damage to the soybean crop can cause a significant decrease in the crude protein content of the soybean. On the other hand, processed soybean meal which is commonly used in monogastric feeding contains about 44-48% crude protein (NRC, 1998). This high crude protein content of soybean and soybean meal in conjunction with high energy due to significant fat content and low fiber content make soybean an ideal source of protein for humans and also ideal feed ingredient in monogastric animals feeding (Table 1). The heat processed soybean is the form primarily used for human consumption and it contains lower crude protein concentration (37%) when compared to soybean meal which is produced from solvent extracted seeds and seeds without hulls (44% and 49% CP, respectively). The soybean meal is the common form of soybean utilized in animal feeding. While other nutrients such as calcium, potassium and zinc also tend to be lower in heat treated soybean than in the soybean meals, the energy and fat content is higher in the heated soybean than the soybean meals.

Previous reports have shown that soybean and soybean meal contains a balanced amino acid profile when compared with other oilseed meals, although it is deficient in methionine and lysine (Zhou et al., 2005). The comparisons of the amino acid composition of soybean and soybean meal which are routinely utilized in human and monogastric feeding are presented in Table 2.

NutrientSoybean seeds2Soybean Meal3Soybean Meal4
IFN55-04-5975-04-6045-04-612
Crude Protein, %374449
Energy, kcal/kg3,3002,2302,440
Crude fat, %180.81.0
Crude fiber, %5.57.03.9
Calcium, %0.250.290.27
Phosphorus6, %-0.650.62
Phosphorus7, %0.530.270.24
Potassium, %1.612.001.98
Iron, mg/kg80120170
Zinc, mg/kg254055

Table 1.

Comparison of selected nutrient composition of soybean and soybean meal1

1National Research Council 1994. 2Heat processed. 3Seeds, meal solvent extracted.


4Seeds without hulls, meal solvent extracted. 5International feed number. 6Total phosphorus.


7Non-phytate or available phosphorus.


Soybean boasts a well balanced amino acid profile with high digestibility when compared with other oilseeds. In soybean, the digestibility coefficients of lysine are estimated to be 91% (NRC, 1994) whereas that of cysteine and phenylalanine is estimated at 83-93 (Bandegan et al, 2010). Previous reports cite evidence that soya is a rich source of amino acids (Angkanaporn et al., 1996). Holle (1995) reported that soybean meal provides the best balance for amino acids when compared with other oilseeds and thus makes it a more suitable plant source protein for human and monogastric food animals. According to Kohl-Meier (1990), soybean accounts for more than 50% of the world’s protein meal. The form in which soybean is utilized for human or monogastric feeding determines the nutritional value in terms of content and bioavailability of amino acids as described in the following section.

2. Anti-nutritional properties of soybean

In their natural form, soybeans contain anti-nutrients or phytochemicals which bear toxic effects when ingested by both humans and monogastric food animals. These anti-nutrients are nature’s means of protection for the soybean plant from invasion by animals, bacteria, viruses and even fungi in the ecosystem. The major anti-nutrients in soybean are phytates, protease enzyme inhibitors, soyin, goitrogens, hemagglutinins or lectins, giotrogens, cyanogens, saponins, estrogens, antigens, non-starch polysaccharides and soy oligosaccharide. Although most of these anti-nutritional compounds in soybean were discussed in Nahashon and Kilonzo-Nthenge (2011), additional reviews of some of the major anti-nutritional factors are presented as follows:

NutrientSoybean seeds2Soybean Meal3Soybean Meal4
IFN65-04-5975-04-6045-04-612
------------------------------------(%)-----------------------------------------
Arginine2.593.143.48
Lysine2.252.692.96
Methionine0.530.620.67
Cystine0.540.660.72
Tryptophan0.510.740.74
Histidine0.901.171.28
Leucine2.753.393.74
Isoleucine1.561.962.12
Phenylalanine1.782.162.34
Threonine1.411.721.87
Valine1.652.072.22
Glycine1.551.902.05
Serine1.872.292.48
Tyrosine1.341.911.95

Table 2.

Comparison of selected amino acid composition of soybean and Soybean meals1

1 National Research Council, 1994.


2 Seeds, heat processed.


3Seeds, meal solvent extracted.


4 Seeds without hulls, meal solvent extracted.


5 International feed number.


2.1. Phytates

Phytic acid (inositol hexakisphosphate), the storage form of phosphorus in seeds such as those of soybean is considered an anti-nutritional factor in monogastric nutrition. Raboy et al. (1984) cited evidence that phytic acid accounted for 67-78% of the total phosphorus in mature soybean seeds and these seed contain about 1.4-2.3% phytic acid which varies with soybean cultivars. In plants phytic acid is the principal store of phosphate and also serves as natural plant antioxidant. Earlier reports (Asada et al., 1969) suggested that phytic acid in soybean not only makes phosphorus unavailable, but also reduces the bioavailability of other trace elements such as zinc and calcium and the digestibility of amino acids (Ravindran, 1999). Ravindran et al., (1999) reported that in the presence of phytate, soybean protein forms complexes with the phytate. Heaney et al. (1991) reported that the absorption of calcium from soybean-based diets was higher in low-phytate soybean when compared with high phytate-soybean. This supports the assertion that soybean has the potential to form phytate-mineral-complex which inhibits the availability of the minerals to monogastric animals. In soybean, phytate is usually a mixture of calcium/magnesium/potassium salts of inositol hexaphosphoric acid which adversely affects mineral bioavailability and protein solubility when present in animal feeds (Liener, 1994). Reports of Vucenik and Shamsuddin (2003) point that inositol bears biological significance as antioxidant in mammalian cells. However, it interferes with mineral utilization and is the primary cause of low phosphorus utilization in soy-based poultry and swine diets. Phytin also chelates other minerals such as Calcium, Zinc, iron, Manganese and Copper, rendering them unavailable to the animals. Soybean has the highest amount of phytate when compared to all legumes and cereal grains. The phytates have been reported to be resistant to cooking temperatures.

2.2. Protease enzyme inhibitors

Proteases refer to a group of enzymes whose catalytic function is to hydrolyze, cleave or breakdown peptide bonds of proteins. They are also called proteolytic enzymes that include trypsin, chymotrypsin, elastase, carboxypeptidase, and aminopeptidase which convert protein (polypeptides, dipeptides, and tripeptides) into free amino acids which are readily absorbed through the small intestine into the blood stream. Protease or trypsin inhibitors of soybean have been reported to hinder the activity of the proteolytic enzymes trypsin and chymotrypsin in monogastric animals which in turn lowers protein digestibility (Liener and Kakade, 1980). Other reports (Liener and Kakade, 1969; Rackis, 1972) confirmed that trypsin inhibitors were key substances in soybean that adversely affected its utilization by chicks, rats and mice. Kunitz, (1946) isolated trypsin inhibitor from raw soybeans and demonstrated that it was associated with growth inhibition. These protease inhibitors were also reported to inhibit Vitamin B12 availability (Baliga et al., 1954). Later studies have also shown that the presence of dietary soybean trypsin inhibitors caused a significant increase in pancreatic proteases (Temler et al., 1984). To the benefit of the soybean plant, soybean protease inhibitors serve as storage proteins in seeds, regulate endogenous proteinases, and also protect the plant and seeds against insect and/or microbial proteinases (Hwang et al., 1978). These protease inhibitors contain about 20% of the sulfur-containing amino acids methionine and cysteine, which are also the most limiting essential amino acids in soybean seeds (Hwang et al., 1978).

Recent reports (Dilger et al., 2004; Opapeju et al. 2006; Coca-Sinova et al. 2008) show that the nutritional value of soybean meal for monogastric animals is significantly hindered by these protease inhibitors which interfere with feed intake and nutrient metabolism. They reported that soybeans with high content protease inhibitors, especially trypsin inhibitors adversely affect protein digestibility and amino acid availability. In earlier reports, Birth et al. (1993) cited evidence that ingestion of food containing trypsin inhibitor by pigs increased endogenous nitrogen losses hence the effect of the trypsin inhibitors affected nitrogen balance more by losses of amino acids of endogenous secretion than by losses of dietary amino acids. This may be due to compromised integrity of the gastrointestinal lining leading to reduction of absorptive surface. However, Gertler et al. (1967) attributed the depression of protein digestibility to reduced proteolysis and absorption of the exogenous or dietary protein which was caused by inhibition of pancreatic proteases.

2.3. Hemagglutinins or lectins

Soybean hemagglutinins or lectins are glycoproteins that resemble some animal glycoproteins, such as ovalbumin and are rich in the acidic amino acids while being low in the sulfur-containing amino acids methionine and cysteine. According to Lis et al. (1966), the only carbohydrates serving as constituents of soybean hemagglutinins are mannose and glucosamine. Soybean hemaglutinins are a component of soybeans that were characterized by Schulze et al. (1995) as being anti-nutritional. Oliveira et al. (1989) reported that these glycoproteins bind to cellular surfaces via specific oligosaccharides or glycopeptides. They exhibit high binding affinity to small intestinal epithelium (Pusztai, 1991) which impairs the brush border and interfere with nutrient absorption. Hemaglutinins have also been implicated in producing structural changes in the intestinal epithelium and resisting gut proteolysis (Pusztai et al., 1990), changes which in most cases result in impairment of the brush border and ulceration of villi (Oliveira et al., 1989). This occurrence result in significant decrease in the absorptive surface and increase endogenous nitrogen losses as reported by Oliveira and Sgarbierri (1986) and Schulze et al. (1995). Consequently, Pusztai et al. (1990) observed that hemagglutinins depressed growth rate in young animals. Hemagglutinins are known to promote blood clotting or facilitating clumping together of red blood cells. It has however been concluded that soybean hemagglutinins play a minor role in the deleterious effect contributed by anti-nutritional factors in raw soybean.

2.4. Giotrogens and estrogens

Soybean is known to produce estrogenic isoflavones which bind to the estrogen receptors. According to Doerge and Sheehan (2002), such estrogenicity was implicated in toxicity and estrogen-mediated carcinogenesis in rats. Genistein is the major soy isoflavones of great concern in conferring estrogenic effect especially in women. Although the possible gitrogenic effect of the soybean isoflavones has not been researched extensively, certain soy components may present some antithyroid actions, endocrine disruption, and carcinogenesis in animals and humans as well. Messina, (2006) reported that Soybean contains flavonoids that may impair the activity of the enzymes thyroperoxidase. Earlier reports (Divi and Doerge, 1996) indicate that plant-derived foods such as soybean contain flavonoids which are widely distributed, possessing numerous biological activities that include antithyroidism in experimental animals and humans. A study was conducted to evaluate inhibition of thyroid peroxidase (TPO), the enzyme that catalyzes thyroid hormone biosynthesis, by 13 commonly consumed flavonoids (Divi and Doerge, 1996). Consequently, most flavonoids tested including genistein and daidzein were potent inhibitors of TPO (Figure 1). They suggested that chronic consumption of flavonoids, especially suicide substrates, could play a role in the etiology of thyroid cancer. More recent reports (Messina, 2006; Xiao, 2008; Zimmermann, 2009) have also shown that use of soy-based formula without added iodine can produce goiter and hypothyroidism in infants, but in healthy adults soy-based products appear to have negligible adverse effects on thyroid function.

Other reports (Fort, 1990) have also shown that concentrations of soy isoflavones resulting from increased consumption of soy-based formulas inhibited thyroxine synthesis inducing goiter and hypothyroidism and autoimmune thyroid disease in infants. Still many questions linger on the full Impacts of soy products on thyroid function, reproduction and carcinogenesis, hence the need for further research in this context. According to Divi et al. (1997), the IC50 values for inhibition of TPO-catalyzed reactions by genistein and daidzein were ca. 1-10 microM, concentrations that approach the total isoflavone levels (ca. 1 microM). More recent finding using normal rats (Chang and Doerge, 2000) however suggest that, even though substantial amounts of TPO activity are lost concomitant to consumptionof soy isoflavone, the remaining enzymatic activity issufficient to maintain thyroid homeostasis in the absence of additional perturbations. On the other hand, additional factors other than the soybean isoflavones can also cause overt thyroid toxicity. These may include other soybean fractions, iodine deficiency, defects of hormone synthesis that may be caused by gene mutations or environmental and random factors including dietary factors that may be goitrogenic.

Environmental estrogens, on the other hand, are classified into two main categories namely phytoestrogens which are of plant origin and xenoestrogens which are synthetic (Dubey et al., 2000). Soybeans contain phytoestrogens which can cause enlargement of the reproductive tract disrupting reproductive efficiency in various species, including humans (Rosselli et al., 2000), and rats (Medlock et al., 1995). In some cases these estrogens are hydrolyzed in the digestive tract to form poisonous compounds such as hydrogen cyanide. Woclawek-potocka et al. (2004) reported that phytoestrogens acting as endocrine disruptors may induce various pathologies in the female reproductive tract. Studies have shown that soy-derived phytoestrogens and their metabolites disrupt reproductive efficiency and uterus function by modulating the ratio of PGF2a to PGE2. Because of the structural and functional similarities of phytoestrogens and endogenous estrogens, there is the likelihood that the plant-derived substances modulate prostaglandin synthesis in the bovine endometrium, impairing reproduction. Previous research has shown that phytoestrogens may act like antagonists or agonists of endogenous estrogens (Rosselli et al., 2000; Nejaty and Lacey, 2001).

Figure 1.

Schematic presentation of inhibition of TPO-catalyzed reactions by genistein and daidzein. TPO:thyroid peroxidase; UDPGT:Uridine diphosphate glucuronyltransferase; TBG:thyroxine binding globulin; TTR: Transthyretin; THr: thyroxine receptor; T:thyroxine; TSH:Thyroid stimulating hormone; TRH:Thyrotropin-releasing hormone; Tg:Thyroglobulin.

2.5. Allergens and antigens

Today, food allergies are a common serious health threat and food safety concern around the world. The increasing use of soybean (Glycine max) products in processed foods owing to its nutritional and health promoting properties, poses a potential threat to individuals who allergic to foods and especially sinsitive to soybean. According to Cordle (2004), there are about 16 potential soy protein allergens that have been identified and the Food and Agriculture Organization of the United Nations includes soy in its list of the 8 most significant food allergens. While many of these soy allergenic proteins have not been fully characterized, their allergenicity can be mild to life-threatening anaphylaxis. Consequently, consumers who have allergies to soybean and soybean products are often at a risk of serious or life threatening allergic reaction if they consume these products.

One of these low abundance proteins, Gly m Bd 30 K, also referred to as P34, is considered to be a dominant immunodominant soybean allergen. It is a member of the papain protease superfamily with a glycine in the conserved catalytic cysteine position found in all other cysteine proteases (Herman et al., 2003). The P34 protein is thought to trigger most allergic reactions to soy and it accumulates during seed maturation localizing in the protein storage vacuoles but not in the oil bodies (Kalinski et al., 1992). Several attempts have been made to understand and remove the allergenic proteins in soybean. Using a "gene silencing" technique, researchers were able to "knock out" a gene that makes Antigenic factors glycinin and β-conglycinin removal increases animal performance.

The prevalence of soybean allergy is estimated at 0.4% in children and 0.3%in adults North America (Sicherer and Sampson, 2010). A study was conducted to determine the relationship between adverse health outcomes and occupational risk factors among workers at a soy processing plant (Cummings et al, 2010). They reported that asthma and symptoms of asthma were associated with immune reactivity to soy dust. Such occurences are a occupational hazard and have led to strict regulatory oversight in soybean plants and food manufacturing plants that process food products containing soybean. There have been numerous recalls by the FDA (FDA Enforcement Reports) of several products containing soy proteins, paste, oils and flour for reasons ranging due to improper labeling. Unlisted soy protein on the product label is considered a potential hazard for people who may be allergic to soy.

2.6. Cyanogens and saponins

Soybean and other closely related legumes which are common food ingredients for human and monogastric animals have been recognized to contain cyanogenic compounds (Montgomery, 1980). The content of cyanide was reported at 0.07-0.3 pg of hydrogen cyanide/g of sample in soy protein products and 1.24 pg/g in soybean hulls when browning was kept to a minimum (Honig et al.,1983). Cyanide is considered toxic even in small amounts, hence where soy are a major constituent of a diet, there are concerns of cyanide toxicity.

On the other hand, saponins are unabsorbable glucosides of steroids, steroid alkaloids or triterpenes found in soybeans germ and cotyledons and other leguminous plants. They form lather in aqueous solutions and impart a bitter test or flavor in feed, resulting in reduction of feed consumption. In severe cases they cause haemolysis of red blood cells and diarrhea (Oakwndull, 1981). Raw soybeans have been reported to contain 2-5 g of saponins/100 g soy products. Although soybean saponins possess anti-nutritional properties, some are edible and have been reported to possess some health benefits. They have been shown to stimulate the immune system, bind to cholesterol and make it unavailable for absorption and allowing its clearance into the colon and eventual excretion (Elias et al., 1990).

2.7. Non-starch polyssacharides and soy oligosaccharides

Soybean oligosaccharides (OS) such as raffinose and stachyose are carbohydrates consisting of relatively small number of monosaccharides and they have been reported to influence ileal nutrient digestibility and fecal consistency in monogastric animals (Smiricky et al., 2002). According to Leske et al., (1993), raffinose and stachyose represent about 4-6% of soybean dry matter. The digestion of OS in the small intestine is limited because mammals lack α-galactosidase necessary to hydrolyze the α 1,6 linkages present in OS (Slominski, 1994). Previous research has demonstrated that soy OS are responsible for increasing intestinal viscosity of digesta and as a result interfere with digestion of nutrients by decreasing their interaction with digestive enzymes (Smits and Annison, 1996). Irish and Balnave (1993) demonstrated that stachyose derived from the oligosaccharides of soyabean meals exert anti-nutritive effects in broilers fed high concentrations soyabean meal as the sole protein concentrate. The OS in soybean, raffinose and stachyose, are not eliminated by heat treatment during processing (Leske et al., 1993). In earlier reports (Coon et al.,1990) observed that removal of the OS from SBM in poultry diets increased the true metabolizable energy value of the diet by 20 percent.

The digestion of oligosaccharides in the small and large intestine is aided by beneficial microbial fermentation (Hayakawa et al., 1990). Certain oligosaccharides, however, are considered to be prebiotic compounds because they are not hydrolyzed in the upper gastrointestinal tract and are able to favorably alter the colonic microflora, conferring beneficial effects of digestion and fermentation of carbohydrates to the host. More recent studies have demonstrated that feeding a higher level of an oligosaccharide (8 g/kg) to chicks depressed metabolizable energy and amino acid digestibility (Biggs et al., 2007). Smiricky-Tjardes et al. (2003) reported the presence of significant quantities of galactooligosaccharides in soy-based swine diets. These soy oligosaccharides are partially fermented by gut microflora functioning as prebiotics which promote selective growth for beneficial bacteria. The high content of enzyme inhibitors in unfermented soybeans interferes with thecomplete digestion of carbohydrates and proteins from soybeans. When foods are not completely digested because of enzyme inhibitors, bacteria in the large intestine try to do the job, and this can cause discomfort, bloating, and embarrassment. The enzyme inhibiting properties of soybean compounds the low levels of digestive enzymes, a common phenomenon especially in elderly people.

3. Modifications of soybean to enhance nutritional value and health benefits

3.1. Genetic modifications (GMO’s)

About 99 percent of the soybean that we consume is genetically modified (GMO) and referred to as GMO soybean. The genetic modifications in soybean are primarily meant to improve the yield and nutritional value of soybean, reduce allergenicity, create resistance to certain diseases or disease causing pathogens and/or confer tolerance to herbicides or adverse climatic or environmental conditions. For example, transgene-induced gene silencing was used to prevent the accumulation of Gly m Bd 30 K protein in soybean seeds. The Gly m Bd 30 K-silenced plants and their seeds lacked any compositional, developmental, structural, or ultrastructural phenotypic differences when compared with control plants (Herman et al., 2003). Current GMO crops, including soybean, have not been shown to add any additional allergenic risk beyond the intrinsic risks already present (Herman 2003).

The enhancement of the nutritional value of soybean and soybean products through genetic engineering of soybeans has been reported. Through genetic engineering completely new fatty acid biosynthetic pathways have been introduced into soybeans from exotic plants and various microorganisms (Cahoon et al., 1999; Wallis, Watts, and Browse, 2002). Soybean oil is used in many food applications and therefore alterring its composition, especially the fatty acid composition would benefit the consumer. Several fatty acids especially the omega-3 have been reported to possess health benefit to the consumer. Engineered soybean lines that are rich in oleic acid (producing stable oil that does not need to be partially hydrogenated and is thus free of trans fatty acids) and lines lower in saturated fatty acids have been produced (Kinney & Knowlton, 1998; Buhr et al., 2002). These high-oleic and low-saturated soybean oils provide the potential benefits to human health and point to the positive impact of the achievements in biotechnology that promote human health.

Bioactive polyunsaturated fatty acids are also known to confer beneficial and positive effects in humans’ health (Knapp et al., 2003). These bioactive fatty acids can also be found in oils other than soybean can also be produced in soybean through genetic engineering. Thus, introducing these into soybean can enhance the existing health benefits of soybean with the complementary benefits of bioactive lipids and other compounds.These polyunsaturated fatty acids are known to mediate their heart-healthy effects by mechanisms independent of those of soy protein and they have been previously researched extensively (Kelley and Erikson, 2003; Knapp et al., 2003).

Previously attempts were made to increase the oxidative stability of soybean oil by increasing the composition in soybean of the fatty acids oleic and stearic and decrease linoleic acid content of the soybean without creating trans or polyunsaturated fatty acids (Clemente, 2009). According to Clemente, (2009) and Clemente and Cahoon, (2009), DuPont announced the creation of a high oleic fatty acid soybean, with levels of oleic acid greater than 80%. This product was due for release into the market in 2010. Soybean mutants with elevated and reduced palmitate have been developed (Rahman et al., 1999). While the palmitate content of commercial soybean cultivars is approximately 11%, elevated palmitate content in soybean oil may be important for the production of some food and industrial products.

Soy foods have also been reported (Sirtori and Lovati, 2001) to have the potential for reducing blood low-density lipoprotein (LDL) cholesterol concentrations in humans. According to Weggemans and Trautwein, (2003), this positive health effect appears to be directly related to the soy storage proteins rather than other components. The bulk of soy protein (more than 80%) is contributed by two major classes of storage protein, conglycinin (11S globulins) and beta-conglycinin (7S globulins). It has been possible to produce soybean transgenic lines with either7Sor no 11S protein using gene-silencing techniques (Kinney & Fader, 2002).

For many years soybean has been defined as a crop with the best amino acid composition within all cultivated protein crops and is most widely utilized for human and monogastric foods as a primary source of protein (Wenzel, 2008). Since the amino acids are directly used in the genetic formation of proteins and fatty acids, this makes the soybean invaluable in oil production and primary protein source of choice to many. There has been attempt through genetic engineering to modifiy the soybean to enhance its oxidative stability by changing the proportion of certain fatty acids, which would provide a more useful and abundant oil supply with health benefits to the consumer. The enhancement of soybean oil content, Clemente et al. (2009) achieved this goal by introducing a seed-specific transgene for a DGAT2-type enzyme from the oil-accumulating fungus Umbelopsis ramanniana into soybean. Without disrupting the protein content, the oil content was increased from approximately 20% of the seed weight to approximately 21.5%.

There has also been an attempt to genetically modify soybean to enhance flavors. These compounds are associated with the oxidation of the polyunsaturated fatty acids linoleic and linolenic acids (Frankel, 1987). There are hundreds of volatile compounds associated with bad flavors in soy preparations (Stephan and Steinhart, 1999), and these compounds are the predominant fatty acids in soybean oil whose oxidation during bean storage and processing results in the formation of secondary products of lipid oxidation that impart off-flavors to soy protein products.

Drought tolerant varieties of soybean have also been developed through genetic engineering. The Roundup Ready soybean, also known as soybean 40-3-2, is a transgenic soybean that has been immunized to the Roundup herbicide. Although soybean’s natural trypsin inhibitors provide protection against pests, weeds still remain a major challenge in soy farming (Wenzel, 2008). An herbicide used to control weeds in soybean farming contained glyphosate which inhibited the expression of the soybean plant’s ESPSP gene. According to Wenzel, (2008), the gene is involved in the maintenance of the “biosynthesis of aromatic metabolites,” and killed the plant along with the weeds for which the herbicide was meant. Consequently, the soybean was genetically engineered by transferring a plasmid which provided immunity to glyphosate-containing herbicides was transferred to the soybean cells through the cauliflower mosaic virus, perfecting the Roundup Ready soybean.

Since drought stress is a major constraint to the production and yield stability of soybean, integrated approaches using molecular breeding and genetic engineering have also provided new opportunities for developing high yield and drought resistance in soybeans (Manavalan et al., 2009). Recently, Yang et al. (2010) pointed out that genetic engineering must be employed to exploit yield potential and maintaining yield stability of soybean production in water-limited environments in order to guarantee the supply of food for the growing human population and for food animals. On the other hand, new soybean varieties that are resistant to diseases and pests are being developed. Hoffman et al. (1999) observed that plants commonly respond to pathogen infection by increasing ethylene production. They suggested that soybean can be altered by genetic manipulation using mutagenesis to generate soybean lines with reduced sensitivity to ethylene. Two new genetic loci were identified, Etr1 and Etr2 and Plant lines with reduced ethylene sensitivity developed similar or less-severe disease symptoms in response to virulent Pseudomonas syringae. Other reports (Yi et al., 2004) indicate that CaPF1, a ERF/AP2 transcription factor in hot pepper plants may play dual roles in response to biotic and abiotic stress in plants and that through genetic engineering this factor could be modified to improve soybean disease resistance as well.

3.2. Enzyme supplementation

The diets of monogastric animals are primarily composed of feed ingredients of plant origin such as soybean. Soybean contains a variety of antinutritional factors such as phytin, nonstarch polysaccharides, and protease inhibitors which limit the availability of nutrients that are essential for normal growth and performance, production or otherwise. Enzyme supplementation and soybean fermentation products have been used for a long time to improve the nutritional value and health-promoting properties of soybean (Kim et al., 1999). Recent reports (Kim et al., 2010) cite evidence that fermented soybean meal can effectively serve as an alternative protein source for nursery pigs at 3-7 weeks of age, possibly replacing the use of dried skim milk which tends to be more digestible than soybean. Feng et al. (2007) evaluated the effect of soybean meal fermented with Aspergillus oryzae on the activity of digestive enzymes and intestinal morphology of broilers. The fermentation had no significant influence on the activity of lipase, amylase and protease enzymes. However, they observed a significant increase in duodenal villus height and a decrease in crypts depth a sign of improved morphology of the absorptive surface. Earlier studies by Kiers et al. (2003) indicated that fermentation of soybean resulted in an increase nutrient solubility and digestibility in broilers.

The availability of phosphorus in soybean is about 30 percent; hence diets of monogastric animals must be supplemented with inorganic phosphorus or supplemented with the phytase enzyme to improve the utilization of phytate phosphorus (NRC, 1994; Richter, 1994). Phytase (myo-inositol-hexakisphosphate phosphohydrolase) is an enzyme that catalyzes the hydrolysis of phytic acid, an indigestible inorganic form of phosphorus in oil seeds such as soybean. As a result, phytases increase the digestion of phosphorus, consequently increasing its utilization and reducing its excretion by monogastric animals. The phytase enzymes commonly used in monogastric animal feeding are derived from yeast or fungi and bacteria. Nahashon et al. (1993) reported that phosphorus retention was improved in layers when the diet was supplemented with Lactobacillus bearing phytase activity. The use of phytase to hydrolyze phosphorus and possibly other mineral elements that may be bound onto phytate such as calcium, zinc, copper, manganese and ion, has been reported (Selle and Ravindran, 2007; Powell et al., 2011).

Recently, Liu et al. (2007) demonstrated that phytase supplementation in soybean-based diets significantly improved the digestibility of phosphorus and Calcium by 11.08 and 9.81%, respectively. A 2- 8% improvement of the digestibility of amino acids was also noted since phytate also binds to protein forming phytate-protein complex. This complex is less soluble resulting in decreased digestibility of soybean protein (Carnovale et al., 1988). Earlier, Singh and Kirkorian (1982) reported that phytate also inhibits trypsin and pepsin activities. These findings suggest that phytase supplementation in soybean-based diets can improve the digestibility of calcium, phosphorus and proteins and indeed amino acids. Augspurger and Baker, (2004) observed that high dietary levels of efficacious phytase enzymes can release most of the P from phytate, but they do not necessarily improve protein utilization (Boling-Frankenbach et al., 2001). Supplemental phytase has also been reported to improving dietary phosphorus utilization by pigs (Sands et al., 2001; Traylor et al., 2001). Other reports (Pillai et al., 2006) demonstrated that addition of E. coli phytase to P-deficient broiler diets improved growth, bone, and carcass characteristics. Most recently Rutherford et al. (2012) demonstrated that addition of microbial phytase to diets of broiler chickens improved significantly the availability of phytate phosphorus, total phosphorus, other minerals such as calcium, zinc, manganese etc. and amino acids.

Protease enzymes on the other hand break down long protein chains into short peptides which can be readily absorbed. These proteolytic enzymes whose catalytic function is to hydrolyze or breakdown peptide bonds of proteins include enzymes such as trypsin, chymotrypsin, pepsin, papain, elastase, plasmin, thrombin, and proteinase K. These enzymes can also be supplemented in feed or indirectly by feeding microbials that have the potential to produce these enzymes in the gastrointestinal tract of the host animals. On the other hand, carbohydrases such as xylanase and amylase are enzymes that catalyze the hydrolysis of carbohydrates into sugars which are readily available or metabolizable by monogastric animals. Soybean meal contains approximately 3% of soluble non-starch polysaccharides (NSP) and 16% of insoluble NSP (Irish and Balnave, 1993). The NSP in soybean is thus of negligible amounts to yield digesta viscosity problems. Therefore, diets that comprise soybean are considered to be highly digestible, hence requiring less use of carbohydrases. Previous reports have, however, pointed out that since these cereal grains contain some soluble NSP, there is still the need to supplement soybean based diets with these enzymes to further improve their nutritional value (Maisonnier-Grenier et al., 2004).

Supplementing soybean based diets with multicarbohydrase enzymes, a preparation containing nonstarch polysaccharide-degrading enzymes, phytases and proteases reveled that these enzymes improved nutrient utilization and growth performance of broiler chickens (Woyengo et al., 2010). Cowieson and Ravindran (2008) reported that when these enzyme combinations were fed in broler diets with both adequate and reduced energy and amino acid content, a 3% and 11% increase in apparent metabolizable energy and nitrogen retention, respectively, were observed. Also feeding other multicarbohydrase combinations containing xylanase, protease, and amylase resulted in significant improvements in feed conversion and body weight gain of broilers (Cowieson, 2005). In their recent review, Adeola and Cowieson (2011) suggested that when used together with phytase, nonstarch polysaccharide-hydrolyzing enzymes may increase the accessibility of phytase to phytin encapsulated in plant cell walls.

Although the enhancement of monogastric animal performance using enzyme supplements in feed have been extensively researched and documented, the benefits of enzymes such as the phytases and multicarbohydrase in soybean-based diets of monogastric animals have not been fully explored and require further research. There is still a great deal of uncertainty regarding the mode of action of these enzymes including the phytases, carbohydrases and proteases and their combination thereof in soybean based diets of monogastric animals. It is just fair to not that the future of enzymes in nonruminant animal production is promising and will require further research to elucidate the role of enzyme supplementation in promoting health and provide an understanding of the modes of action of these enzymes in modulating gene functions and their interactions thereof.

3.3. Probiotics and prebiotics supplementation

Probiotics, also known as direct-fed microbials, are live microbial feed supplements which beneficially affect the host animal by improving its intestinal microbial balance (Fuller, 1989). They have been reported to improve feed consumption, feed efficiency, health and metabolism of the host animal (Cheeke, 1991). The total collection of these probiotics, other gut microflora, their genetic elements or genomic materials and their interactive environment or the gastrointestinal tract of the host is termed the “microbiome”. Currently efforts are underway to understand the microbiome and elucidate the mode of action of both probiotics and prebiotics due to a great interest in these gut microbiota and their health promoting properties and enhancement of performance of humans and monogastric animals. The scientific basis for the modes of action of probiotics and prebiotics is, therefore, beginning to emerge. According to report of Quigley (2012) a number of human disease states may benefit from the use of probiotics; these include diarrheal illnesses, inflammatory bowel diseases, certain infectious disorders, and irritable bowel syndrome. Prebiotics promote the growth of “good” bacteria, primarily through competitive exclusion resulting in a variety of health benefits. Probiotics have also been reported to: (1) improve feed intake and digestion and production performance (Nahashon et al., 1994a, 1994b, 1994c, 1996), (2) maintain a beneficial microbial population by competitive exclusion and antagonism (Fuller, 1989), and (3) alter bacterial metabolism (Cole et al., 1987; Jin et al., 1997). Nahashon et al (1994a) evaluated the phytase activity in lactobacilli probiotics and the role in the retention of phosphorus and calcium as well as egg production performance of Single Comb White Leghorn laying chickens. They reported phytase activity in the direct-fed microbial and that supplementation of the corn-soy based diets with the probiotics to a 0.25% available phosphorus diet improved phosphorus retention and layer performance.

Prebiotics are defined as non-digestible food ingredients that beneficially affect the host, selectively stimulating their growth or activity, or both of one or a limited number of bacteria in the colon and thus improve gut health (Gibson and Roberfroid, 1995). They are short-chain-fructo-oligosaccharides (sc-FOS) which consist of glucose linked to two, three or four fructose units. They are not absorbed in the small intestine but they undergo complete fermentation in the colon by colonic flora (Gibson and Roberfroid, 1995). They benefit humans and monogastric animals by: (1) releasing volatile fatty acids which are absorbed in the large intestine and contribute to the animal's energy supply; (2) enhance intestinal absorption of nitrogen, calcium, magnesium, iron, zinc and copper in rats (Ducros et al., 2005); (3) increase the number and/or activity of bifidobacteria and lactic acid bacteria (Hedin et al., 2007); and (4) since they are non-digestible, they provide surface for attachment by pathogenic bacteria and therefore facilitate the excretion of these pathogenic microorganisms.

According to Bouhnik et al. (1994) and Gibson and Roberfroid, (1995), fructooligosaccharides such as inulin, oligofructose, and other short-chain fructooligosaccharides can be fermented by beneficial bacteria such as bifidobacteria and lactobacilli and in turn control or reduce the growth of harmful bacteria such as Clostridium perfringens through competitive exclusion. The bifidobacteria and lactobacilli are generally classified as beneficial bacteria (Gibson and Wang, 1994; Flickinger et al., 2003). Although the mode of action of several of these oligosaccharides are still obscure, Biggs et al. (2007, pointed out that even low concentrations (4 g/kg) of an indigestible oligosaccharide can be fed to monogastric animals with no deleterious effects on metabolizable energy and amino acid digestibility. The benefit of utilizing oligosaccharides in soy-based diets of monogastric animals are due to the ability of these oligosaccharide to pass through to the hindgut of the monogastric animals intact and to be fermented by beneficial bacteria that are stimulated to grow and produce compounds that are beneficial to the host. These beneficial bacteria are also able to prevent the growth of bacteria such as Escherichia coli and Clostridium perfringens that can be harmful to the host through competitive exclusion (Gibson and Roberfroid, 1995). Biggs and Parsons (2007) reported an increase in the digestibility of a few amino acids was by some oligosaccharides in cecectomized roosters.

3.4. Amino acids and vitamin supplementation

Soybean is an excellent source of protein and vegetable oil for human and animal nutrition due to its balanced amino acid profile. According to Berry et al. (1962), methionine is the most limiting amino acid followed by lysine, and threonine. The level of supplementation of the amino acids lysine, methionine, threonine and glycine was evaluated (Waguespack et al., 2009). Feed efficiency decreased significantly in broilers fed diets supplemented with more than 0.3% L-Lysine but not in birds fed diets containing 0.25% L-Lysine. It was also observed that up to 0.25% L-Lysine could be added to corn-soy diets of broilers supplemented with methionine, threonine and glycine. Waguespack et al. (2009) also reported that arginine and valine were equally limiting after methionine, threonine and glycine in the diets containing 0.25% L-Lysine.

Earlier reports (Douglass and Persons, 2000) demonstrated a significant improvement in feed efficiency by methionine and Lysine supplementation in broilers diets. Studies have shown that excess heating by extrusion cooking or autoclaving of soybean during oil extraction can decrease lysine availability, hence requiring supplementation of this and other amino acids in soybean meal-based diets (Persons et al., 1992). It has also been further established that supplementation of raw soybean meal with methionine is an effective way of eliminating the potential nutritional deficiencies in both the raw and heated soybean meals. Due to the fact that raw soybean contains protein of low quality, supplementation of pig raw soy-based diets with cysteine and the B-complex vitamins exhibited significant improvement in performance (Peterson et al., 1941). Evaluating the effect of supplementation of turkey diets with dL-tocopheryl acetate, Sell et al. (1997) reported that feeding soybean based diets containing 6-20 IU tocopheryl acetate/kg improved performance of male turkeys from 1-day of age to market age.

3.5. Heat treatment and autoclaving

Heat treatment is a common procedure in soybean processing during extraction of oil and the inactivation of antinutritional factors such as trypsin inhibitors. The processing inactivates these protease inhibitors, although there has to be a balance in conditions of heat inactivation since excessive heating could also destroy other essential nutrients. Kwok et al. (1993) demonstrated that excess heat in the inactivation of protease inhibitors of soybean may increases Maillard reactions between the amino group of amino acids and reducing sugars and as a result decrease the digestibility of energy and amino acids by monogastric animals. Comparing the nutritive value of different heat treated commercial soybean meals, Veltmann et al. (1986) reported that compared to the normal meal, excessively heat-treated soybean meal had lower crude protein which also reflected lower essential and non-essential amino acids, and less trypsin inhibitors. Herkelman et al. (1991) evaluated the effect of heating time and sodium metabisulfite (SMBS) on the nutritional value of full fat soybeans for chicks. They observed that chicks fed the full-fat soybean achieved maximum performance when the soybeans were heated at 121 o C for 40 min, and the SMBS decreased by one half the heating times required inactivating trypsin inhibitors.

4. Health benefits of soybean in human nutrition

4.1. General overview

Soybeans which boast rich content of protein (38-40%) of high quality and with a balanced amino acids profile are widely grown around the world and are the most important world source of edible oil and protein. Besides it’s use in livestock feeds and to some extent biofuels, soybean is processed into products that are utilized for human consumption such as soybean oil and fermented soybean products which have long been utilized to prepare healthy human foods worldwide (Kim et al., 1999). Highly purified and oil-free food grade proteins isolates containing as high as 95% crude protein are commonly utilized in human foods. In the United States, 90% of the soybean is used for food especially as soybean oil (Smith and Wolf, 1961). In Asia and other parts of the world, soybean and soybean products are routinely utilized in large quantities in various forms of foods such as mature soybean, soybean flour, soybean meal, soybean milk, and also as oriental soybean products such as tofu, natto, miso, shoyu, and sprouts. In the recent past there has been increased focus on soybean as human food because of its health benefits. As a result, considerable research effort has been directed to evaluating the health benefits and increasing the uses of soybean in human foods. Abundant supplies of high protein soybean products and the rapid development of the soybean processing industry has also contributed significantly to the increased use of soybean as human food.

4.2. Selected components of soybean that confer health benefits

Soybean and soybean products have been acclaimed to confer health benefits to consumers because they contain substances that have been confirmed to bear health conferring properties. These substances include Iron, isoflavones, high content of protein rich in balanced amino acids, the sulfur containing amino acids methionine and cysteine, saponins, phytoestrogens, and the omega-3 fatty acids present in soybean oil. Soybeans are a major source of nonheme iron in diets of humans. Although some of the iron is unavailable for it is in the form of ferritin complexed with phytate, calcium and proteins, iron in soybean is a bioavailable source for human consumption. On the other hand, the benefits of omega-3 long chain fatty acids to heart health are well established (Lemke et al., 2010) and enrichment of soybean oil with these fatty acids has been a sustainable way of increasing tissue concentration of these omega-3 fatty acids and in reducing the risk of cardiovascular disease.

Soybean also contains nonstarch polysaccharide (NSP) hydrolysis products of soybean meal. These nonstarch polysaccharide hydrolysis products of soybean meal are beneficial in maintaining fluid balance during Enterotoxigeic Escherichia Coli (ETEC) infection and controlling ETEC-induced diarrhea in piglets. Soybean fermented with R. oligosporus produce antibacterial compounds that are active against some gram-positive microorganisms. The material can be extracted with water from soybeans fermented by R. oligosporus. Genistein and other soybean isoflavones slow the growth of blood vessels to tumors, another action that makes it popular as a cancer fighter.

4.3. Disease prevention properties of soybean

4.3.1. Cholesterol

Soybean, a popular source of protein for both humans and other monogastric animals due to its protein content and quality, especially the balance of amino acids, is an invaluable source of oil which contains fatty acids known to be effective in prevention of cardiovascular disease. The US Food and Drug Administration (1999) indicated that soybean proteins were responsible for prevention of cardiovascular disease. According to Lovatti et al. (1996) the soybean 7S or β-conglycinin has also been implicated in the upregulation of liver high-affinity LDL receptors. This protein was also shown to reduce plasma triglycerines in humans and rats (Aoyama et al., 2001). Later studies (Duranti et al., 2004) evaluated the effect of soybean 7S globulin subunits on the upregulation of LDL receptors. They reported that it lowered the expression of β-VLDL receptors induced by soybeam subunit. The oral admoinistration of soybean 7S globulin and the α-subunit significantly reduced plasma cholesterol and tryglycerides of hypercholesterolemic rats (Duranti et al., 2004). On the other hand, feeding soybean (25 g/day) was associated with lower total cholesterol concentrations in individuals with initial cholesterol concentratons of greater than 5.7 mmol/L (Bakhit et al., 1994). Later studies (Carroll, 1991) demonstrated that soybean protein lowered blood lipids in humans and experimental animals. Sirtori et al. (1985) also demonstrated that a 50% substitution of animal protein with soybean protein significantly reduced blood cholesterol concentrations of humans with type II familial hypercholesterolemia.

Soybean fiber has also been reported to reduce blood lipids whereas comsumption of cookies containing 25 g soybean cotyledon fiber was associated with a significant reduction in total plasma LDL cholesterol in hypercholesterolemic patients (Lo et al., 1986). Various mechanisms of reduction of cholesterol in humans and other monogastric animals have been proposed. These include the direct effect of soybean peptides which may modulate the endocrine regulation of catabolism and/or reduction in cholesterol biosynthesis (Bakhit et al., 1994). Most recently, Cho et al. (2007) suggest that soy peptides can effectively stimulate LDL-R transcription in the human liver cell line and reduce blood cholesterol level. They proposed several mechanism and component of the cholesterol lowering activity of soybean which include blockage of bile acid and/or cholesterol absorption, inhibition of cholesterol synthesis, and stimulation of low-density lipoprotein receptor (LDL-R) transcription. Similar observations were reported earlier by Beynen et al. (1986) that hypocholesterolemic effect of dietary soybean protein was caused primarily by its influence on the heterohepatic circulation of bile acids and cholesterol.

4.3.2. Cancer

Soybean is a rich protein source for humans and monogastric animals and contains about 0.2-1.5 mg/g of the isoflavones daidzein and genistin, and their glycones daidzein and genistkein (Wang and Murphy, 1994). These isoflavones have been proposed to possess anticarsinogenic properties which may be associated with their ability to serve as antioxidants which prevent fat rancidity, β-carotene bleaching and glutathione peroxidase activity (Hendrich et al., 1994), antiestrogens, and inhibiting the estrogen synthetase preadipocyte aromatase in humans (Aldercreutz et al., 1993). Adlercreutz et al. (1991) suggested that the low breast cancer incidence in Japanese women may be attributed to their consumption of feeds rich in soybean, a source of isoflavones. These isoflavones in soybean such as genistein confer anticarcinogenic effect primarily by inhibiting estrogen binding to the estrogen receptors; the soy isoflavones compete for estrogen receptors.

Xu et al. (1995) also hypothesized that soybean isoflavones possess anticarsinogenic properties. They anaerobically incubated soybean isoflavones with human feces and observed that intestinal half life daidzein and genistein were as little as 7.5 and 3.3 hrs, respectively. Hence the bioavailability of these isoflavones was depended on the ability of gut microflora to degrade these compounds. They attributed the cancer protective effects of the isoflavones to also the isoflavone metabolites such as methyl p-hydroxyphenylacetate, a monophenolic compound of both exogenous flavonoids and tyrosine which are inhibitors of hormone-dependent neoplastic cell proliferation. This compound has high affinity for nuclear type II binding site which is involved in cell growth regulation by estrogenic hormones (Xu et al., 1995).

In his report, Messina (1999) stated that soybean isoflavones may reduce the risk of prostrate cancer in men and breast cancer in women. The anti-cancer properties in soybean are attributed to the isoflavone genistein which influence signal transduction and the potential role in preventing and treating cancer. McMichael-Phillips et al. (1998) observed a significant enhancement of DNA synthesis by breast cells taken from biopsies of normal breast tissue from women with benign and malignant breast disease when these women were fed soybean for about two weeks. On other studies (Jing et al., 1993) reported that daidzein, one of the two primary isoflavones in soybean exhibited anti-cancer effects by inhibiting the growth of HL-60 cells implanted into the subrenal capsules of mice. The anticancer effects of the isoflavone genistein may be attributed to its antioxidant properties and its ability to inhibit several enzymes that are involved in signal transduction (Wei et al., 1993) including tyrosine protein kinase (Akiyama et al., 1987), ribosomal S6 kinase (Linassier et al., 1990), Map kinase (Thoburn et al., 1994), the inhibition of the activity of DNA topoisomerase and increasing the concentration of transforming growth factor β (TGFβ) as reported by Benson and Colletta (1995).

The interest in soybean and soybean products has been driven by its potential health benefits, especially in prevention of various forms of cancer by the soybean isoflavones genistein, deidzein and glycitein. In more recent studies, Su et al. (2000) reported that isoflavones played a protective role against bladder cancer cells. They also observed that both genistein and combined isoflavones exhibited significant tumor seppressing effects. According to Messina and Barnes (1991), increased soybean consumption reduced the risk of breast, colon and breast cancer for people living in Asia as opposed to people living in the United States and Western Europe. A comprehensive review of the interelationship between diet and cancer by The World Cancer Research Fund (1997) revealed that vegetable intake decreased the risk of colon cancer. The increased consumption of soybean and soybean products have also been reported to reduce the risk of colon cancer in some human and animal populations.

While examining the ability of dietary soybean components to inhibit the growth of prostate cancer, Zhou et al. (1999) reported that dietary soybean products inhibited experimental prostrate tumor growth through direct effects in the tumor cells and indirectly through the effect on tumor neurovesculature. Earlier reports (Herbert et al., 1998) showed that increased consumptio of soybean products contributed to reduction in prostrate cancer risk. Phytochemicals in soybean have been reported to posses anticarcinogenic properties (Messina et al., 1994). Zhou et al. (1999) further observed that soybean isoflavones and phytochemicals inhibited LNCaP cell proliferation, blocked cell cycle progression and enhanced DNA fragmentation which is a marker for opoptosis or programmed cell death. Datta et al., (1997) reported that soybean is capable of oxidizing benzo (a) pyrene-7, 8-dihydrodiol and 2-aminofluorine which are known to cause developmental toxicity or transplacental carcinogenicity in mammals. In other studies, Wei et al., (1995) cited evidence that genistein's antioxidant properties and antiproliferative effects may be responsible for its anticarcinogenic effects. Therefore, high content of genistein in soybean and its high bioavailability increases soybean's potential for prevention of various forms of cancer.

Soybean saponins have also been cited as potential contributors to the health promoting properties of soybean and soybean products. Saponins are chemical structures consisting of triterpenoidal or steroidal aglycones with various carbohydrates moieties in plants. Saponins are excellent emulsifyers since they bear both hydrophilic and hydrophobic regions and they tend to inhibit colon tumor cell proliferation in vitro. Various saponins have demonstrated antimutagenic and anticarcinogenic effecta against cell lines. More recent studies (Ellington et al., 2005) suggested that the B-group soyasaponins may be colon cancer suppressive component os soybean serving as potential chemopreventative phytochemical. Therefore, soybean and soybean products should be explored further for their potential in prevention and treatment of the various forms of cancer.

4.3.3. Osteoporosis

Osteoporosis is a degenerative thinning of the bones that is associated with decreasing estrogen levels which is a common problem with aging, especially in women. According to Ikenda et al. (2006), soybeans and soybean products which contain large amounts of menaquinone-7 (vitamin K2) may help prevent the development of osteoporosis. Soybeans have also generated interest in connection with osteoporosis because they contain a phytoestrogens called isoflavones, which are believed to have potential as substitute for estrogen without its adverse side effects. Intake of Natto, an ancient Japanese food of fermented soybeans, was reported to bear properties that were preventative of postmenopausal bone loss through the effects of menaquinone-7 or bioavailable isoflavones which were more abundant in natto than in other soybean products (Ikenda et al., 2006). Heaney (1996) described vitamin K functionally as a cofactor of γ-carboxylase enzyme which mediates the conversion of undercarboxylated osteocalcin to carboxylated osteocalcin by transforming the glutamyl residue of osteocalcin into carboxyglutamic acid residue. The carboxyglutamic acids have high affinity for calcium ions in hydroxyapatite and regulate the growth of these crystals in bone formation. Therefore there is sufficient evidence to suggest that fermented soybean products can effectively maintain bone stiffness (Katsuyama et al., 2002) by increasing serum levels of menaquinone-7 and γ-carboxylated osteocalcin (Kaneki et al., 2001) as well as maintaining bone mineral density.

Soybean and soybean-based diets for human contain naturally occurring bioactive compounds known as phytochemicals that have been cited to confer long-term health benefits (Setchell, 1998). These phytoestrogens primarily occur as glycosides bearing a weak estrogen-like activity which allows them to bind to the estrogen receptor (Miksicek, 1994) and therefore are of great significance as remedy where estrogen levels decline due to old age. These isoflavones can serve as alternative to estrogen therapy in the treatment of existing low bone mass or osteoporosis. They present potential naturally occuring alternative to hormone or drug therapy (estrogen) that would minimize bone loss in menopausal women.

In other studies, Picherit et al. (2001) assessed the dose-dependent effect of daily soybean isoflavones consumption in reversing bone loss in adult ovariectomized rats. They reported that in adult ovariectomized rats, daily soybean isoflavone consumption decreased bone turnover but did not reverse established osteopenia. In earlier studies using a rat model, Arjmandi et al. (1996) evaluated the potential for soybean protein isolate to prevent bone loss induced by ovarian hormone deficiency. They reported an increase in femoral and vertebral bone densities in rats that were fed soybean diets possibly due to the presence of isoflavones in soybean.

5. Nutritional benefits of soybean in other monogastric animals

5.1. Poultry

Soybean meal is the primary protein source in corn-soy based poultry rations. It is fed to poultry as soybean meal and is primarily the by-product of soybean oil extraction; it’s the ground defatted flakes. Various studies have been conducted to evaluate methods of enhancing the acceptability of soybean and the enhancement of its nutritional value in poultry feeding. For instance, a study was conducted to evaluate the effect of extruding or expander processing prior to solvent extraction on the nutritional value of soybean meal (SBM) for broiler chicks. The results of this study indicate that pre-solvent processing method (expander or non-expander) had no significant effect on the nutritional value of SBM for broiler chicks. Both Methionine and Lysine supplementation increased feed efficiency (Douglas and Persons, 2000). Several other studies (Coca-Sinova et al. 2008; Dilger et al. 2004; Opapeju et al. 2006) have evaluated various methods of enhancing the digestibility of individual amino acids and protein of soybean meal.

The guinea fowl is classified as poultry and although its production is not popular as chickens, it is gradually gaining popularity and acceptance as alternative meat to chicken. It is also gradually finding its share of the global market for poultry and poultry products. Lacking however, is estimates for nutrient requirements of the guinea fowl. Recent efforts have focused on evaluating the growth pattern of the guinea fowl (Nahashon et al. 2010) and their nutrient requirements (Nahashon et al. 2009, 2010, 2011). The soybean meal has been utilized extensively as the sole protein source for the guinea fowl providing accurate estimate for the nutrient requirements for both the Pearl Grey and French varieties of the guinea fowl.

5.2. Swine

Soybean meal and soybean products have also been used extensively in swine production because of its relatively high concentration of protein (44 to 48%) and its excellent profile of highly digestible amino acids. Soy protein provides most amino acids that are deficient in most cereal grains commonly fed as energy sources in swine production. However, as opposed to feeding animal source proteins, when raw soybean is fed to young pigs as the primary protein source, dramatic slowdown in body weight gains were reported even with supplementation of amino acids such as methionine and cysteine (Peterson et al., 1942). The animal source proteins tend to exhibit higher digestibility than plant source proteins such as soybean and therefore better suited for nursery pigs (Kim et al., 2009; Gottlob et al., 2006). The low digestibility of raw soybean by young pigs is therefore attributed to the low nutritive value of the raw soybean protein. Due to the high cost of feeding and also the antinutritional factors in raw soybean, there have been attempts to minimize the amount of soybean in swine rations and also to improve its digestibility. The digestibility of the amino acids of soybean by swine has also been researched quite extensively (Smiricky-Tjardes et al. 2002; Grala et al., 1998; NRC 1998).

The supplementations of raw soybean with the amino acids threonine and the B- complex vitamins have been reported to enhance growth in young pigs. Also fermented soybean meals, soybean meals with enzyme supplements and extruded soybean meals have been used extensively in swine diets and they tend to improve performance especially of young pigs (Kim et al., 2006). Kim et al. (2009) reported an increase in crude protein concentration from 50.3 to 55.3% by fermentation of soybean meal with A. oryzae without affecting the balance of limiting amino acids for pigs. Bruce et al. (2006) evaluated the inclusion of soybean (SB) processing byproducts such as gums, oil, and soapstock into soybean meal. Addition of these processing by-products significantly reduced the nutritive value of the resultant meal. Smiricky-Tjardes et al. (2003) evaluated other approaches such as the addition of galactooligosaccharides on ileal nutrient digestibility to enhance and expand the utilization of soybean in swine production.

5.3. Aquatic life

The feeding value of soybean as a rich protein source has also been extended to aquaculture. The high protein level makes soybean meal a key ingredient for aquaculture feeds since soybean meal is considerably less expensive than traditionally used marine animal meals. However, soybeans not contain complete amino acid profiles and usually are deficient in the essential amino acids lysine and methionine. Therefore, other protein sources should be used in combination with soybean to overcome the deficiencies. Soybean meal and genetically modified soybean products have also been employed in aquaculture (Hammond et al. 1995). Naylora et al. (2009) points to the importance of fish oils and fishmeal as a protein source in food animal production and also the extensive use of soybean and soybean products as protein supplements in aquaculture feeds.

5.4. Companion animals

The term “companion animals” refers to the entire spectrum of animal species which are considered as 'pets' such as cats, dogs, fish, rabbits, rodents, cage birds, and even non-indigenous species. Large animals such as horses, as well as small ruminants such as the goats and sheep have also been classified as companion animals as well because they contribute to human companionship; they have an important role to play in our society. The companion animal industry is rapidly growing sector of the global economy and so is the need for provision of adequate nutritional regimens for optimum growth, production and reproduction. Relatively few data are available on the nutrient digestibilities of plant-based protein sources by companion animals.

Plant source proteins such as soybean and soybean products are predominantly used in diets of companion animals. Soybeans are an essential part of Plant-based protein sources and are generally less variable in chemical composition than animal-based protein sources especially in nutrients such as calcium and phosphorus. The effects of including selected soybean protein sources in dog diets on nutrient digestion at the ileum and in the total tract, as well as on fecal characteristics, were evaluated (Clapper et al. 2001). Apparent amino acid digestibility at the terminal ileum, excluding methionine, threonine, alanine, and glycine, were higher (P < 0.01) for soybean protein-containing diets when compared with diets containing other sources of protein.

The effects of soybean hulls containing varying ratios of insoluble: soluble (I: S) fiber on nutrient digestibility and fecal characteristics of dogs were evaluated (Burkhalter et al., 2001). Ileal digestibility of dry matter by dogs fed the soybean hulls treatments responded quadratically (P < 0.05) to I: S fiber diets, with digestibility coefficients decreasing as the I:S approached 3.2. In other studies (Tso and Ling, 1930) reported that the blood cholesterol value of rabbits is slightly higher in animals fed the soybeans diets than in controls. However, differences in cholesterol levels between rabbits fed on cooked and raw soybeans were not statistically significant. Also the blood of rabbits fed exclusively on water-soaked raw soybeans showed an increase in uric acid, urea nitrogen, inorganic phosphorus and cholesterol. After extending this study to feeding cooked soybeans, there are no demonstrable changes in the blood composition of rabbits whether they were fed cooked or raw soybeans.

The optimum concentration of a mixture of soybean hulls and defatted grape seed meal (SHDG) for rabbits was evaluated (Necodemus et al. 2007). They observed that SHDG could be included up to 26.7% in diets for fattening rabbits and lactating does that meet ADL and particle size requirements. In another study, Angora goat doelings (average BW 22.1 kg) were used to examine the effects of dietary crude protein level and degradability on mohair fiber production (Sahlu et al. 1992). They reported that plasma glucose was elevated 2 hours after feeding in the goats fed conventional, solvent-extracted soybean meal, whereas glucagon concentrations were greater at 0 and 4 h in the group fed expelled, heat-treated soybean meal.

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Samuel N. Nahashon and Agnes K. Kilonzo-Nthenge (February 20th 2013). Soybean in Monogastric Nutrition: Modifications to Add Value and Disease Prevention Properties, Soybean - Bio-Active Compounds, Hany A. El-Shemy, IntechOpen, DOI: 10.5772/52991. Available from:

chapter statistics

2182total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Effects of Hydrogenation on Soybean Oil

By Fred A. Kummerow

Related Book

First chapter

Potential of Medicinal Use of Essential Oils from Aromatic Plants

By Mozaniel Santana de Oliveira, Marcos Martins Almeida, Marielba de Los Angeles Rodriguez Salazar, Flávia Cristina Seabra Pires, Fernanda Wariss Figueiredo Bezerra, Vânia Maria Borges Cunha, Renato Macedo Cordeiro, Glides Rafael Olivo Urbina, Marcilene Paiva da Silva, Ana Paula Souza e Silva, Rafael Henrique Holanda Pinto and Raul Nunes de Carvalho Junior

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us